BioMimetic Therapeutics' Series C Round

BioMimetic Therapeutics raised a round of funding on April 22, 2005.

BioMimetic Pharmaceuticals (BMTI) is a biopharmaceutical company focused on the development, commercialization and ultimate marketing of protein therapeutics for tissue and organ regeneration. The Com…

Articles about BioMimetic Therapeutics' Series C Round: